the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
October 08, 2010 – Today, we learn that Abbott Laboratories and FDA notified healthcare professionals and patients about the voluntary market withdrawal of Sibutramine [Meridia], an obesity drug, from the U.S. market because of clinical trial data indicating an increased …
Sibutramine [Meridia]: Market Withdrawal Due to Risk of Serious Cardiovascular events Read more »
September 24, 2010 – Please find below a very significant announcement by the European Medicines Agency (EMEA) regarding the market suspensions of Avandia throughout the European Union. 09/23/2010 – The European Medicines Agency today recommended the suspension of the marketing …
September 23, 2010 – We present here a very significant announcement by the American Food and Drug Administration (FDA) in its original. Please note that the European Medicines Agency (EMEA) also today recommended the suspension of the marketing authorisations for …
FDA Significantly Restricts Access to the Diabetes Drug Rosiglitazone [Avandia] Read more »